C. Hugh Friedman 
The Honorable Lynn Schenk, is Director and member of the Governance and Nominating Committee for Biogen Idec, Inc. Ms. Schenk has been on the Biogen Idec Board since 1995. She will be joined by C. Hugh Friedman, professor at USD is a frequent presenter on corporate governance issues and securities law. They will come to the studio to explore the different issues on how a director gets selected to be on the board. We will explore their perspective on how they would go about getting the best people on your board.
LISTEN: SEGMENT ONE
Hear about the evolution of the board room dynamics through the personal careers of the Honorable Lynn Schenk and C. Hugh Friedman. Lynn was on her first board in 1978 and Hugh is responsible for publishing the two volume 'California Practice Guide: Corporations.'
LISTEN: SEGMENT TWO
The process of selecting a Director is much more formal and no longer a rubber stamp. Lynn highlights some of the points out of the Biogen Idec 8 point plan in finding and selecting a new director.
LISTEN: SEGMENT THREE
Hugh highlights that SOX has been a main driver in changing how boards and their nominating committees select new directors. One of the important element is to have independent directors and one aspect we explore is the number of boards a director can be on at the same time.
LISTEN: SEGMENT FOUR
The importance of chemistry in the boardroom. Do all these rules still allow room for taking the chemistry in consideration? How do boards deal with this in the interview process. Especially now that many of these new potential directors are mostly not personally known prior to the interview process.
